Fig. 2From: Evidence of extensive cellular immune response after SARS-CoV-2 vaccination in ocrelizumab-treated patients with multiple sclerosisSpearman correlation analysis of SARS-CoV-2 specific IgG and Spike (S) 1 specific ELISpot responses in patients with multiple sclerosis (n = 10). The bold, continuous line indicates the regression line, the dashed lines the 95% confidence intervalBack to article page